OraPharma Inc. (acquired by JNJ)

company

About

OraPharma is a specialty pharmaceutical company that develops and commercializes products that help improve and maintain oral health.

  • 51 - 100

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$16M
Industries
Health Care,Pharmaceutical
Founded date
Jan 1, 1996
Number Of Employee
51 - 100
Operating Status
Active

OraPharma is a specialty pharmaceutical company that develops and commercializes products that help improve and maintain oral health. They are dedicated to delivering scientifically and technologically advanced products to dental professionals and their practices.


ARESTIN® (minocycline HCl) Microspheres, 1 mg is a locally administered antibiotic (LAA) offering a patented microsphere technology. OraPharma is proud to have introduced this revolutionary approach to treating periodontitis as an adjunct to scaling and root planing and continues to take a leadership role in educating clinicians and consumers on the disease. Read more about ARESTIN® or click here for Prescribing Information.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$16M
OraPharma Inc. (acquired by JNJ) has raised a total of $16M in funding over 2 rounds. Their latest funding was raised on Dec 14, 1998 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 14, 1998 Series Unknown $16M 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
OraPharma Inc. (acquired by JNJ) is funded by 2 investors. Senmed Medical Ventures and Biotechnology Investments are the most recent investors.
Investor Name Lead Investor Funding Round
Senmed Medical Ventures Series Unknown
Biotechnology Investments Series Unknown